Increased Frequency of Pre-germinal Center B Cells and Plasma Cell Precursors in the Blood of Children with Systemic Lupus Erythematosus1
暂无分享,去创建一个
[1] P. Lipsky,et al. Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus1 , 2000, The Journal of Immunology.
[2] J. D. Capra,et al. Identification of centerin: a novel human germinal center B cell‐restricted serpin , 2000, European journal of immunology.
[3] D. Alarcón-Segovia,et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. , 2000, Arthritis and rheumatism.
[4] J. Choe,et al. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL‐10 , 2000, European journal of immunology.
[5] D. Isenberg,et al. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. , 2000, Arthritis and rheumatism.
[6] V. Dixit,et al. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI , 2000, Current Biology.
[7] A. Komiyama,et al. CD27: a memory B-cell marker. , 2000, Immunology today.
[8] Don Foster,et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.
[9] D. Lacey,et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..
[11] P. Cohen,et al. Spontaneous and induced apoptosis in systemic lupus erythematosus: multiple assays fail to reveal consistent abnormalities. , 1999, Cellular immunology.
[12] L. Rassenti,et al. The soluble CD40 ligand sCD154 in systemic lupus erythematosus. , 1999, The Journal of clinical investigation.
[13] R. Bataille,et al. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. , 1999, Blood.
[14] Amy S Orr,et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. , 1999, Science.
[15] C. Bombardier,et al. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. , 1999, Arthritis and rheumatism.
[16] M. Shlomchik,et al. The central and multiple roles of B cells in lupus pathogenesis , 1999, Immunological reviews.
[17] M. Shlomchik,et al. A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus , 1999, The Journal of experimental medicine.
[18] R. Vakkalanka,et al. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. , 1999, Arthritis and rheumatism.
[19] K. Rajewsky,et al. Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells , 1998, The Journal of experimental medicine.
[20] M. Cooper,et al. Impairment of T and B Cell Development by Treatment with a Type I Interferon , 1998, The Journal of experimental medicine.
[21] Virginia Pascual,et al. Somatic Hypermutation Introduces Insertions and Deletions into Immunoglobulin V Genes , 1998, The Journal of experimental medicine.
[22] E. Terpos,et al. Systemic lupus erythematosus presenting as myelofibrosis. , 1998, Haematologia.
[23] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database. , 1997, Nucleic acids research.
[24] J. Harley,et al. Lupus and interleukin 10. , 1997, The Journal of rheumatology.
[25] J. Banchereau,et al. Memory B Cells Are Biased Towards Terminal Differentiation: A Strategy That May Prevent Repertoire Freezing , 1997, The Journal of experimental medicine.
[26] C. Mohan,et al. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. , 1997, Journal of immunology.
[27] J. Freed,et al. Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. , 1997, Clinical immunology and immunopathology.
[28] M. Shlomchik,et al. The Roles of B Cells in MRL/lpr Murine Lupus , 1997, Annals of the New York Academy of Sciences.
[29] C. Arpin,et al. Germinal center development , 1997, Immunological reviews.
[30] R de Groot,et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. , 1997, The Journal of pediatrics.
[31] J. Banchereau,et al. Germinal Center Founder Cells Display Propensity for Apoptosis before Onset of Somatic Mutation , 1997, The Journal of experimental medicine.
[32] G. Tsokos,et al. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. , 1996, The Journal of clinical investigation.
[33] M. Jourdan,et al. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice , 1996, The Journal of experimental medicine.
[34] K. Rajewsky. Clonal selection and learning in the antibody system , 1996, Nature.
[35] J. Banchereau,et al. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. , 1996, Seminars in immunology.
[36] J. Banchereau,et al. Normal human IgD+IgM- germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts. , 1996, Immunity.
[37] R. Ramsey‐Goldman,et al. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. , 1996, The Journal of clinical investigation.
[38] J. Banchereau,et al. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. , 1996, Immunity.
[39] A. Kuramoto,et al. Identification of early plasma cells in peripheral blood and their clinical significance , 1996, British journal of haematology.
[40] J. Banchereau,et al. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype , 1996, The Journal of experimental medicine.
[41] G. Kelsoe,et al. In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self- tolerance , 1995, The Journal of experimental medicine.
[42] J. Banchereau,et al. Human follicular dendritic cells enhance cytokine-dependent growth and differentiation of CD40-activated B cells. , 1995, Journal of immunology.
[43] J. Banchereau,et al. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. , 1995, International immunology.
[44] A. Steinberg,et al. Inquiry into Murine and Human Lupus , 1995, Immunological reviews.
[45] D. Alarcón-Segovia,et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus , 1995, The Journal of experimental medicine.
[46] M. Shlomchik,et al. The role of B cells in lpr/lpr-induced autoimmunity , 1994, The Journal of experimental medicine.
[47] J. D. Capra,et al. Analysis of somatic mutation in five B cell subsets of human tonsil , 1994, The Journal of experimental medicine.
[48] G. Kelsoe,et al. In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells , 1993, The Journal of experimental medicine.
[49] N. Fineberg,et al. Reference ranges for lymphocyte subsets in pediatric patients. , 1993, American journal of clinical pathology.
[50] I. Maclennan,et al. Recombinant 25‐kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis , 1991, European journal of immunology.
[51] G. Kelsoe,et al. In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations , 1991, The Journal of experimental medicine.
[52] S. Ha,et al. The acute lupus hemophagocytic syndrome. , 1991, Annals of internal medicine.
[53] T. Sakane,et al. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus. , 1989, Journal of immunology.
[54] N. Rosenthal,et al. Bone marrow findings in connective tissue disease. , 1989, American journal of clinical pathology.
[55] H. Hochkeppel,et al. MX HOMOLOGOUS PROTEIN IN MONONUCLEAR CELLS FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS , 1989, Arthritis and rheumatism.
[56] M. Okamura,et al. Serum levels of interferons in patients with systemic lupus erythematosus. , 1987, Clinical and experimental immunology.
[57] M. Peterson,et al. A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. , 1984, Arthritis and rheumatism.
[58] M. Peterson,et al. A comparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. , 1984, Arthritis and rheumatism.
[59] R. Friedman,et al. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon , 1983, The Journal of experimental medicine.
[60] A. Steinberg,et al. Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. , 1980, The American journal of medicine.
[61] D. Alarcón-Segovia,et al. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. , 1978, Arthritis and rheumatism.
[62] D. Alarcón-Segovia,et al. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. , 1978, Arthritis and rheumatism.
[63] A. Denman. Anti-lymphocytic antibody and autoimmune disease: a review. , 1969, Clinical and experimental immunology.